Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Collegium Pharma (NQ: COLL ) 32.72 -0.74 (-2.21%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Collegium Pharma < Previous 1 2 3 Next > S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday September 05, 2024 Via Benzinga Topics Stocks Exposures US Equities The Analyst Landscape: 4 Takes On Collegium Pharmaceutical September 05, 2024 Via Benzinga Dr. Reddy's Stock Hit All-Time High Last Month. Ready To Climb Again? September 03, 2024 Dr. Reddy's Labs sees its Relative Strength Rating enter the 80-plus level. Via Investor's Business Daily Organon Stock Sees Relative Strength Rating Rise To 91 August 27, 2024 On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before. Via Investor's Business Daily Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold August 20, 2024 On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier. Via Investor's Business Daily The Analyst Verdict: Collegium Pharmaceutical In The Eyes Of 4 Experts August 09, 2024 Via Benzinga Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews May 10, 2024 Via Benzinga Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know April 11, 2024 Via Benzinga Where Collegium Pharmaceutical Stands With Analysts February 23, 2024 Via Benzinga COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace In a market where value is scarce, NASDAQ:COLL offers a refreshing opportunity with its solid fundamentals. August 06, 2024 COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying. Via Chartmill NASDAQ:COLL is an undervalued gem with solid fundamentals. July 16, 2024 COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying. Via Chartmill Dr. Reddy's Labs Stock Sees Improved Technical Strength June 28, 2024 On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76. Via Investor's Business Daily 7 Biotech Stocks to Buy on the Dip: June 2024 June 24, 2024 With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation. Via InvestorPlace NASDAQ:COLL appears to be flying under the radar despite its strong fundamentals. June 24, 2024 COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is an undervalued gem with solid fundamentals. Via Chartmill Recap: Collegium Pharmaceutical Q4 Earnings February 22, 2024 Via Benzinga Analyst Expectations For Collegium Pharmaceutical's Future February 02, 2024 Via Benzinga Why Collegium Pharmaceutical Shares Are Gaining Today January 03, 2024 Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial Via Benzinga COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday January 03, 2024 U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a... Via Benzinga Topics Stocks Exposures US Equities Recap: Collegium Pharmaceutical Q3 Earnings November 07, 2023 Via Benzinga Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know August 25, 2023 Via Benzinga Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday August 04, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Recap: Collegium Pharmaceutical Q1 Earnings May 04, 2023 Via Benzinga Earnings Outlook For Collegium Pharmaceutical February 22, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 07, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday February 07, 2023 It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday! Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session February 06, 2023 Via Benzinga Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve August 08, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 August 08, 2022 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
